Patient with multiple myeloma and suspected cardiac amyloidosis (RCD code: III‑3A.2a)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 2
Abstract
49 year‑old patient with multiple myeloma diagnosed a year earlier, after a few cycles of chemotherapy was admitted to hospital with heart failure symptoms accompanied by a rapid atrial flutter. Echocardiography revealed eccentric hypertrophy of the left ventricle and reduced ejection fraction approx. 20% and non sustained ventricular tachycardia episodes in the Holter ECG. Due to the gradually deteriorating patient’s condition electrical cardioversion was performed restoring sinus rhythm. Applied pharmacological treatment brought relief of symptoms reported at admission. To clarify the etiology of heart failure coronary angiography was performed excluding the presence of coronary artery disease. Because of the frequent occurrence of amyloidosis in patients with multiple myeloma, the amyloid cardiomyopathy was suspected and the investigation in that direction was started. Histology samples of abdominal fat and gums mucous in a hematoxylin and eosin and Sirius red staining showed no signs of amyloidosis. However, bone marrow biopsy revealed the presence of protein corresponding to the extracellular amyloid deposits. The patient died a few months later in hematology clinic due to severe multiple organ failure associated with generalized amyloidosis. JRCD 2015; 2 (2): 22–25
Authors and Affiliations
Piotr Liszniański, Jacek Nowak
Keywords
Related Articles
- EP ID EP245457
- DOI 10.20418/jrcd.vol2no2.172
- Views 101
- Downloads 0
Severe course of dilated cardiomyopathy associated with Duchenne muscular dystrophy (RCD code: III‑1A.3a)
Inherited neuromuscular disorders, such as dystrophin-related disorders are frequently associated with cardiac involvement, mainly with cardiomyopathies. Dystrophin-related disorders are caused by the mutation in the dys...
Establishing the optimal dose of nitric oxide in acute vasoreactivity testing in patients with pulmonary hypertension with use of the Bronchial Control Treatment System (RCD code: II)
The key point in the diagnostic algorithm for pulmonary hypertension plays the pulmonary reactivity testing, the agent most frequently used in the test is inhaled nitric oxide (iNO). Various dosages of iNO were used in a...
Adult patient with truncus arteriosus type I. Management and follow‑up (RCD code: IV‑1C.3b)
Truncus arteriosus is a congenital heart malformation where systemic, pulmonary and coronary circulation is supplied by a single artery arising from the heart. Surgical correction of this disorder remains the treatment...
Journal of Rare Cardiovascular Diseases: “Conquering new territories” – a new educational program on rare diseases for medical acolytes
Dear Readers,Nowadays, we witness dramatic changes in the perception of rare diseases. Thanks to the European Union(EU) regulations but more importantly due to increasing pressure from the spontaneous patients’ organiza...
Arrhythmogenic right ventricular cardiomyopathy complicated by thrombus formation (RCD code: III-4)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is caused by replacement of myocardial cells by lipocytes and fibrocytes. The disease is associated with life-threatening ventricular arrhythmias. Echocardiography...